# Cdymax (India) Pharma Private Limited – FDA Inspection, May 17, 2019

Source: https://www.keypedia.com/records/fda_inspections/cdymax-india-pharma-private-limited/af0d07d5-0d83-4b81-886c-3d7911eee80b
Source feed: FDA_Inspections

> FDA inspection 1093684 of Cdymax (India) Pharma Private Limited, May 17, 2019. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1093684
- Company Name: Cdymax (India) Pharma Private Limited
- Inspection Date: 2019-05-17
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 1271325 - 2025-04-25](https://www.keypedia.com/records/fda_inspections/cdymax-india-pharma-private-limited/a643d37d-6f70-40f5-a91d-a549b5742e4b)
- FDA Inspection 1118683 - 2020-01-31
- FDA Inspection 940635 - 2015-08-14

## Related Officers

- [Company Rep](https://www.keypedia.com/people/gam-s-zamil/75bc04d4-6013-43b5-8200-8b513c814a7c)

Company: https://www.keypedia.com/companies/cdymax-india-pharma-private-limited/51bc8d84-9900-43c0-8e1c-9d2bd08b0ac4

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8